These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 10953020)

  • 21. Signaling pathways in insulin action: molecular targets of insulin resistance.
    Pessin JE; Saltiel AR
    J Clin Invest; 2000 Jul; 106(2):165-9. PubMed ID: 10903329
    [No Abstract]   [Full Text] [Related]  

  • 22. [Insulin resistance and molecular abnormalities of the insulin receptor in type II diabetes].
    Clauser E; Assan R
    Journ Annu Diabetol Hotel Dieu; 1993; ():23-36. PubMed ID: 8392640
    [No Abstract]   [Full Text] [Related]  

  • 23. Molecular genetic analysis of NIDDM. Status and prospects.
    Poller W; Schatz H
    Exp Clin Endocrinol; 1993; 101(2):58-68. PubMed ID: 8405141
    [No Abstract]   [Full Text] [Related]  

  • 24. [Disorder of glucose metabolism in skeletal muscle].
    Horike N; Asano T
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():136-40. PubMed ID: 15779357
    [No Abstract]   [Full Text] [Related]  

  • 25. [A new panorama for understanding the molecular connections between obesity and type 2 diabetes mellitus].
    Fernández-Mejía C
    Rev Invest Clin; 2001; 53(3):209-11. PubMed ID: 11496706
    [No Abstract]   [Full Text] [Related]  

  • 26. Age-dependent changes in phenotypes and candidate gene analysis in a polygenic animal model of Type II diabetes mellitus; NSY mouse.
    Ueda H; Ikegami H; Kawaguchi Y; Fujisawa T; Nojima K; Babaya N; Yamada K; Shibata M; Yamato E; Ogihara T
    Diabetologia; 2000 Jul; 43(7):932-8. PubMed ID: 10952468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
    Hong EG; Jung DY; Ko HJ; Zhang Z; Ma Z; Jun JY; Kim JH; Sumner AD; Vary TC; Gardner TW; Bronson SK; Kim JK
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1687-96. PubMed ID: 17911348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Glucose transporter (GLUT4)].
    Ogihara T; Asano T
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():577-82. PubMed ID: 12238102
    [No Abstract]   [Full Text] [Related]  

  • 29. Insulin resistance and the disruption of Glut4 trafficking in skeletal muscle.
    Mueckler M
    J Clin Invest; 2001 May; 107(10):1211-3. PubMed ID: 11375407
    [No Abstract]   [Full Text] [Related]  

  • 30. The Gordon Wilson Lecture. Lessons about the control of glucose homeostasis and the pathogenesis of diabetes from knockout mice.
    Kahn CR
    Trans Am Clin Climatol Assoc; 2003; 114():125-48. PubMed ID: 12813916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetics of type 2 diabetes: insight from targeted mouse mutants.
    Accili D; Kido Y; Nakae J; Lauro D; Park BC
    Curr Mol Med; 2001 Mar; 1(1):9-23. PubMed ID: 11899245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Current advance in insulin signal transduction].
    Ogawa W
    Nihon Rinsho; 2001 Sep; 59(9):1847-55. PubMed ID: 11554062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disease model: hyperinsulinemia and insulin resistance. Part A-targeted disruption of insulin signaling or glucose transport.
    Sone H; Suzuki H; Takahashi A; Yamada N
    Trends Mol Med; 2001 Jul; 7(7):320-2. PubMed ID: 11425641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Knockout mice lacking GLUT4 glucose transporters.
    Dutour A
    Eur J Endocrinol; 1996 Apr; 134(4):421-2. PubMed ID: 8640287
    [No Abstract]   [Full Text] [Related]  

  • 35. Metabolic and molecular basis of insulin resistance.
    Bajaj M; Defronzo RA
    J Nucl Cardiol; 2003; 10(3):311-23. PubMed ID: 12794631
    [No Abstract]   [Full Text] [Related]  

  • 36. Cellular insulin action and insulin resistance.
    Garvey WT; Birnbaum MJ
    Baillieres Clin Endocrinol Metab; 1993 Oct; 7(4):785-873. PubMed ID: 8304915
    [No Abstract]   [Full Text] [Related]  

  • 37. The genetics of non-insulin-dependent diabetes mellitus.
    Pillay TS; Langlois WJ; Olefsky JM
    Adv Genet; 1995; 32():51-98. PubMed ID: 7741025
    [No Abstract]   [Full Text] [Related]  

  • 38. Severe insulin resistance, diabetes mellitus, hypertriglyceridemia, and pseudoacromegaly.
    Kumar S; Durrington PN; O'Rahilly S; Laing I; Humphreys PJ; Olukoga AO; Bhatnagar D; Mackness MI; Davis JR; Boulton AJ
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3465-8. PubMed ID: 8855786
    [No Abstract]   [Full Text] [Related]  

  • 39. Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism.
    Bruce CR; Carey AL; Hawley JA; Febbraio MA
    Diabetes; 2003 Sep; 52(9):2338-45. PubMed ID: 12941774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NIDDM enigma.
    Lancet; 1990 May; 335(8699):1187-8. PubMed ID: 1971038
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.